Pressurized chemotherapy for gastric cancer spread in abdomen
Part of Cancer clinical trials.
This trial tests a specialized chemotherapy delivery method called PIPAC—where chemotherapy is sprayed directly into the abdomen under pressure—for patients with gastric cancer that has spread to the abdominal lining. The goal is to deliver stronger doses of chemotherapy directly to where the cancer is, potentially helping patients who aren't candidates for major surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18–80 years old
- Good overall health status (able to care for yourself with minimal help)
- Gastric (stomach) adenocarcinoma (cancer) confirmed by biopsy with spread to abdominal lining
- Blood counts adequate (white blood cells, neutrophils, and platelets at safe levels)
- Kidney and liver function adequate (normal creatinine, bilirubin levels)
- No cancer spread outside the abdomen (no liver metastases or fluid around lungs)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of treatments for stomach cancer that has spread to the lining of the abdomen. The goal is to see if this approach can shrink or control the cancer, potentially making surgery possible.
This trial tests a new way to give chemotherapy directly into the belly as a fine mist (called PIPAC) for people whose cancer has spread there. The goal is to see if it’s safe and helps shrink or control the cancer.
This trial tests a new way to give chemotherapy – as a fine mist sprayed directly into the belly during a short laparoscopy (keyhole surgery). It is for people whose stomach, pancreas, or colon cancer has spread to the lining of the belly, and who haven't had much chemotherapy before.
This trial tests a new way to deliver chemotherapy directly into the abdomen using a spray (called PIPAC) in people with stomach cancer that has spread to the lining of the belly. The aim is to see if it can help control the cancer with fewer side effects.
This trial tests a new way to give chemotherapy directly into the abdomen during surgery for stomach cancer that has a high risk of coming back. It may help reduce the chance of the cancer returning.
This trial tests whether adding a special type of chemotherapy sprayed directly into the abdomen (PIPAC) to standard chemotherapy is safer and works better for stomach cancer that has spread only to the lining of the abdomen.
Hear when a new Gastric Cancer Peritoneal Metastases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.